Saw Palmetto (Serenoa repens) in Men with Lower Urinary Tract Symptoms: Effects on Urodynamic Parameters and Voiding Symptoms

Urology ◽  
1998 ◽  
Vol 51 (6) ◽  
pp. 1003-1007 ◽  
Author(s):  
Glenn S Gerber ◽  
Gregory P Zagaja ◽  
Gregory T Bales ◽  
Gerald W Chodak ◽  
Barbara A Contreras
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Serenoa Repens ◽  
Saw Palmetto ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
Urodynamic Parameters ◽  
Lower Urinary

scholarly journals Effect of Calcium Channel Blockers on Lower Urinary Tract Symptoms: A Systematic Review

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Muhammad Salman ◽  
Amer Hayat Khan ◽  
Syed Azhar Syed Sulaiman ◽  
Junaid Habib Khan ◽  
Khalid Hussain ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Calcium Channel ◽  
Lower Urinary Tract Symptoms ◽  
Calcium Channel Blockers ◽  
Lower Urinary Tract ◽  
Channel Blockers ◽  
Inverse Association ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Background. Numerous medications are known to be associated with the development of lower urinary tract symptoms (LUTS). One such medication group is calcium channel blockers (CCB). Objective. To critically examine the literature regarding the involvement of CCB in manifestation of LUTS in humans. Methods. A systematic literature search was conducted on PubMed, SciELO, Scopus, and OpenGrey databases to find all potentially relevant research studies before August 2016. Results. Five studies met the inclusion criteria and were included in this review. Three out of five studies stated that CCB were involved in either precipitation or exacerbation of LUTS. As for the remaining two studies, one study found out that only the monotherapy of CCB was associated with increased prevalence of nocturia and voiding symptoms in young females, whereas the other study reported an inverse association of CCB with LUTS. The methodological quality of studies was considered high for four studies and low for one study. Conclusion. Healthcare providers should make efforts for an earlier identification of the individuals at risk of LUTS prior to the commencement of CCB therapy. Moreover, patients should be counselled to notify their healthcare provider if they notice urinary symptoms after the initiation of CCB.

scholarly journals Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients

2021 ◽  
Vol 11 (6) ◽  
pp. 712
Author(s):  
Mikolaj Przydacz ◽  
Marcin Chlosta ◽  
Tomasz Golabek ◽  
Piotr Chlosta
Keyword(s):  
Urinary Tract ◽  
Overactive Bladder ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Population Level ◽  
Computer Assisted ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
And Behavior ◽  
Lower Urinary

Background: The aim of this study was to perform a cross-sectional study of Polish neurogenic patients to measure, at the population level, the prevalence, bother and behavior associated with treatment for lower urinary tract symptoms (LUTS) and overactive bladder (OAB). Methods: This epidemiological study was based on data from LUTS POLAND, a computer-assisted and population-representative telephone survey. Participants were classified by age, sex and place of residence. Results: LUTS POLAND includes 6005 completed interviews, of which 1166 (19.4%) were for individuals who had ever received any treatment by neurologists and/or neurosurgeons. Among these neurogenic participants, LUTS prevalence was 72.3%, statistically higher than for non-neurogenic respondents. At the population level, neurogenic patients had about a 20% higher risk for LUTS presence than non-neurogenic participants (relative risk: 1.17–1.21). LUTS prevalence did not differ between men and women. Frequency was the most common of the LUTS. Forty percent of neurogenic respondents described having more than one LUTS subtype (i.e., storage, voiding, and/or post-micturition symptom subtype), and more than 50% of respondents reported OAB symptoms. Both storage and voiding symptoms were bothersome, and many neurogenic individuals (42.3–51.0%) expressed anxiety about bladder function affecting quality of life. Only one-third (34.9–36.6%) of neurogenic participants had sought treatment for their LUTS, and the majority of such individuals received and maintained treatment. Conclusions: LUTS and OAB symptoms were highly prevalent and bothersome among Polish neurogenic patients at the population level. Because the scale of seeking treatment for LUTS was low, Polish neurogenic patients may not be adequately informed about multiple effects of LUTS and OAB.

scholarly journals LOWER URINARY TRACT SYMPTOMS

2016 ◽  
Vol 23 (11) ◽  
pp. 1340-1344
Author(s):  
Mumtaz Rasool ◽  
Muhammad Shahzad Saleem ◽  
Muhammad Waqas ◽  
Mudassar Saeed Pansota ◽  
Shafqat Ali Tabassum
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Cross Sectional Study ◽  
Common Symptom ◽  
Health Service Provider ◽  
Cross Sectional ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Introduction: Lower urinary tract symptoms are one of the commonestpresentation in urology clinics. Lower Urinary tract symptoms include storage symptoms(frequency, urgency, urge incontinency and nocturia), voiding symptoms (hesitancy, dysuria,intermittency, poor stream of urine, terminal dribbling and residual urine sensation). Correctdetermination of prevalence of LUTS might help the health service provider to plan appropriatemanagement strategies. So this study was designed to determine frequency of LUTS in menaged 40 or above. Study Design: Descriptive, cross sectional study. Period: January 2015to December 2015. Setting: Urology Department of Bahawal Victoria Hospital, Bahawalpur.Materials & Methods: Total 228 patients of 40-80 years of age with lower urinary tract symptomswere included. Patients with foleys in situ, previously operated for urinary tract disease, urinarytract stones and urinary bladder mass were excluded. These patients were assessed todetermine frequency of lower urinary tract symptoms. Results: Mean age was 65.69 ± 7.91years. Mean duration of disease was 5.36 ± 2.19 months. Frequency of LUTS was seen in 138(60.53%) men with urgency in 22.81%, nocturia in 57.89%, frequency in 19.30%, poor streamin 15.79%, incomplete emptying of bladder in 33.33%, urge incontinence in 22.81%, terminaldribbling in 55.26% and hesitancy in 15.16% men. Conclusion: This study concluded thatthe frequency of lower urinary tract symptoms were urgency in 22.81%, nocturia in 57.89%,frequency in 19.30%, poor stream in 15.79%, incomplete emptying of bladder in 33.33%, urgeincontinence in 22.81%, terminal dribbling in 55.26% and hesitancy in 15.16% patients of age≥40 years with nocturia being the most common symptom and frequency of all symptomsincreases with age.

Sign in / Sign up

Export Citation Format

Share Document